|
Over the
last nine years he has continued active involvement in the evolution of
manufacturing science through consultancy with major pharmaceutical
companies, PAT equipment vendors and regulatory agencies:
-
supporting
Process Analytical Technology (PAT) initiatives from design to regulatory
approval
-
identifying
technology providers capable of providing integrated solutions for such
initiatives
-
stimulating and
promoting dialogue between industry and major regulatory agencies in the
above areas
-
as a member of
the scientific advisory board of a number of innovator companies Carrying
out “due diligence” reports for venture capital investors
He was also a member of The British Pharmacopoeia Committee E - Antibiotics
and The European Pharmacopoeia Committee 10C – Synthetic Products.
Externally he has been involved in the
establishment of:
-
Centre of Process Analytics and Control
Technology
-
The London School of Pharmacy NIR Centre of
Excellence
-
The Royal Pharmaceutical Society’s New
Technology Forum
-
FDA’s PAT initiative as an invited member of
the steering group
-
ASTM
Committee E55 - Pharmaceutical Application of Process Analytical
Technology
-
European Pharmaceutical Review as Editor
His
expertise in the PAT area is widely recognised as a regular contributor,
programme coordinator and chair of national and international meetings on
the topic held by the following organisations:
-
American Association of Pharmaceutical
Scientists
-
International Society for Pharmaceutical
Engineering
-
FDA’s Current Series of International PAT
Forums
-
FIP
-
International Forum on Process Analytical
Technology
-
Royal Pharmaceutical Society
Ken's
other interests include:
-
The Royal Society of Chemistry Automation and Analytical Management Group
-
In 1989 he was a member or the RSC Analytical Division Working Party
responsible for the report - "The Future of Analytical Science" and in
consultancy he co-authored the discussion paper - “A strategic Framework
for Analytical Science in the UK” commissioned by the DTI which acted as a
catalyst for the UKAP initiative.
-
The Royal Society of Chemistry/ Royal Pharmaceutical Society Joint
Pharmaceutical Analysis Group
-
The Royal Pharmaceutical Society New Technologies Forum
-
Chair of ASTM Pharmaceutical Application of Process
Analytical Technology Committee E55.01
___________________________________
|
